GeneLink, Inc.
GNLKQ
$0.00
$0.000.00%
OTC PK
| 09/30/2013 | 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | |
|---|---|---|---|---|---|
| Net Income | 35.95% | 23.52% | 1.31% | 20.32% | -14.28% |
| Total Depreciation and Amortization | -7.31% | -11.49% | -11.71% | -20.56% | -31.03% |
| Total Amortization of Deferred Charges | 57.10% | 58.66% | 71.70% | 59.02% | -23.13% |
| Total Other Non-Cash Items | 175.04% | 171.61% | 172.07% | -197.58% | -194.22% |
| Change in Net Operating Assets | -63.34% | -50.23% | -0.41% | 163.99% | 1,809.18% |
| Cash from Operations | 52.74% | 39.01% | 26.90% | 17.83% | -2.83% |
| Capital Expenditure | 98.11% | 92.33% | -308.48% | -484.54% | -87.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -78.48% | -56.15% | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -101.49% | -58.79% | -119.37% | 818.12% | 313.29% |
| Total Debt Issued | -- | -- | -- | -- | 77.04% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.56% | 19.61% | -19.33% | -32.42% | -39.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2,740.77% |
| Cash from Financing | -88.89% | -32.85% | -48.42% | -53.78% | -5.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -276.02% | 77.08% | -252.77% | -286.87% | 90.49% |